Industry News
Pharmaceutical Industry News
Most drug licensing deals with…
Most drug licensing deals with China will be safe from rules being drafted by the U.S. Treasury Department, Reuters reports. Akeso and Summit's ivonescimab, B7-H3 ADCs and a surprise negative overall survival trend from Enhertu
A.I. Agents as ‘Co-Scientists’? This Lab Says They Could Speed Drug Research.
A.I. is already a powerful tool for scientific discovery. Now, some biomedical researchers are teaching it to do even more.
Ultragenyx scored a belated…
Ultragenyx scored a belated regulatory win with FDA approval for a first-in-disease gene therapy, giving the company a boost after a previous regulatory rejection and a recent late-stage setback.
The heart and kidney med earned…
The heart and kidney med earned the first FDA nod in three decades for adults with chronic kidney disease associated with type 1 diabetes.
How proactive risk management,…
How proactive risk management, transparency and flexible communication can turn a CDMO relationship into a true strategic partnership.
Following the news that longtime…
Following the news that longtime helmsman Paul Chaplin would be hanging up his hat at Bavarian Nordic earlier this year, the Danish vaccine maker has found a CEO replacement whose CV spans leadership roles across
Roche’s T-cell engager portfolio…
Roche’s T-cell engager portfolio has notched another milestone, as a phase 3 trial of the company’s Lunsumio met its primary endpoint in earlier-line follicular lymphoma.
Eli Lilly is marking World…
Eli Lilly is marking World Alzheimer’s Day with a partnership to distribute 13,500 boxes of brain-healthy fresh produce and educational materials to underserved senior populations across the U.S.
Sun Pharma is teaming up with…
Sun Pharma is teaming up with fashion designer Christian Siriano for a new educational campaign focused on the positives of regrowing lost hair.
The comedian sat down with Fierce…
The comedian sat down with Fierce to discuss his health advocacy journey as a type 2 diabetic and his work using comedy and humor to bring light to sight-related diabetes complications in Genentech's "All Eyes
Former Publicis Health Media CEO…
Former Publicis Health Media CEO Andrea Palmer has revealed her next post. The executive has taken the CEO position at Assembled Intelligence, the agency that Minds + Assembly launched last year to integrate its flurry
Novo CEO Mike Doustdar—tapped to…
Novo CEO Mike Doustdar—tapped to breathe new life into the Danish drugmaker last year after losing GLP-1 marketing ground to chief rival Eli Lilly—isn’t one to make changes for the sake of change.
It’s time for pharma marketers…
It’s time for pharma marketers to up their ask of AI—not just making better decisions, but building smarter systems that learn from every outcome.
After a 2024 rebuff, AstraZeneca…
After a 2024 rebuff, AstraZeneca and Daiichi Sankyo’s star antibody drug conjugate Enhertu has been deemed cost effective for NHS use in HER2-low advanced breast cancer by England and Wales' drug value assessor.
New phase 3 data show Vera…
New phase 3 data show Vera Therapeutics’ Trutakna successfully stabilizes kidney function in IgA nephropathy patients, mirroring an earlier clinical success from Otsuka’s Voyxact and heating up competition in a rapidly evolving market race.
Cellares is partnering with…
Cellares is partnering with Taiwanese biotech GenomeFrontier Therapeutics to evaluate the integrated contract developer and manufacturer’s cell shuttle platform for use in the production of virus-free CAR-T therapies.
Trialynx takes home the DPHARM…
Trialynx takes home the DPHARM Idol Disrupt award from the 2026 DPHARM conference.
As Amgen advances its bid to join…
As Amgen advances its bid to join the first wave of biosimilars to Bristol Myer Squibb and Ono’s oncology megablockbuster Opdivo, the originator drug’s partners are not taking the challenge lying down.
The health and hygiene…
The health and hygiene conglomerate, known for brands like Lysol and Mucinex, will spend the funds building out an R&D hub at its new headquarters and finalizing the largest of its seven manufacturing sites by
Legend Biotech has found its…
Legend Biotech has found its permanent CEO, poaching 15-year Novartis veteran Ingrid Zhang as the CAR-T specialist eyes its next phase of growth.